C9orf72 and amyotrophic lateral sclerosis: Genetic heterogeneity—such as differences in C9orf72 repeat expansion frequency—as well as population‐specific variations in metabolic or nutritional status, may modulate hematologic biomarkers and alter their relationship with ALS susceptibility or progression.